Nycomed’s performance was driven by strong growth of Key Products and in most emerging markets. This overall positive performance could not fully offset the expected negative impact of pantoprazole’s patent expiry in Europe. Daxas® (roflumilast) is advancing well: Nycomed received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human [...]
Read More
Bayer Schering Pharma AG, Germany, will establish a U.S. Innovation Center in San Francisco, Calif. with the goal to expand its global research network and build its specialty pharmaceutical pipeline.
The model introduces a newly formed “Science Hub” for innovation sourcing in the U.S. creating collaborations with academic research scientists and small biotech firms to realize [...]
Award for Bilobil in Poland Saturday, 01 September 2007 The first place in the national competition “Consumer’s Laurel 2007″ in the category “Drugs for memory improvement” has been won by Krka’s Bilobil. As in the last year, also this year Bilobil won the first place in its category. The award was based on voting by [...]
Read More